ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression

ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression

Background: Resistance to platinum-based chemotherapy is a major cause of therapeutic failure during the treatment of epithelial ovarian cancer (EOC) patients. Our study aims to elucidate the molecular mechanisms by which ZNF711 down regulation promotes CISPLATIN resistance in EOC. Methods: ZNF711 e...

Full description

Bibliographic Details
Main Authors: Geyan Wu, Hu Peng, Miaoling Tang, Meisongzhu Yang, Jun Wang, Yameng Hu, Ziwen Li, Jun Li, Zheng Li, Libing Song
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:EBioMedicine
Subjects:
Epithelial ovarian cancer
Chemo resistance
ZNF711
Histone methylation
BIX-01294
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003510

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003510

Similar Items